Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
1999-1-19
|
pubmed:abstractText |
The efficacy of steroid therapy for active myocarditis is controversial, so a new scoring system was constructed based on 6 clinical parameters: (1) the mode of onset of the disease; (2) complications of immune-related systemic disorders; (3) evidence of viral infection; (4) the population of infiltrating inflammatory cells; (5) the appearance of multinucleated giant cells in endomyocardial biopsy specimens; and (6) the duration of active myocarditis. Points from -2 to +2 were assigned to each parameter and the total score was calculated from the 6 parameters. Twenty-one patients with clinically suspected myocarditis, who had been admitted to hospital from 1987, were retrospectively analyzed by this scoring system. Sixteen patients were treated without corticosteroids at presentation, and 5 patients were treated by conventional methods with adjunctive use of corticosteroids. In 10 patients of the non-steroid group myocarditis improved and their mean score was -4.8 at presentation. In 6 patients of the non-steroid group, myocarditis and cardiac symptoms persisted after initial therapy, and their score at presentation was -0.8. In 2 patients of the steroid group myocarditis improved after initial therapy and their score was +2. In 2 other patients of the steroid group, myocarditis and cardiac symptoms persisted and their score was +3. Another patient of the steroid group died from congestive heart failure and his score was -5 at presentation. In 8 of 9 patients with persistent myocarditis, the secondary phase therapy was challenged. Seven patients were treated with corticosteroids and 6 patients improved. Their score at the secondary phase was +2.5. Overall, non-steroid conventional treatment was successful in patients with the scores from -5 to -4, and steroid therapy succeeded in patients with scores from 0 to +6. Although this is a retrospective study, this scoring system is able to predict the efficacy of steroid therapy in patients with clinically suspected active myocarditis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0047-1828
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
62
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
715-20
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9805250-Acute Disease,
pubmed-meshheading:9805250-Adult,
pubmed-meshheading:9805250-Factor Analysis, Statistical,
pubmed-meshheading:9805250-Female,
pubmed-meshheading:9805250-Humans,
pubmed-meshheading:9805250-Male,
pubmed-meshheading:9805250-Methylprednisolone,
pubmed-meshheading:9805250-Middle Aged,
pubmed-meshheading:9805250-Myocarditis,
pubmed-meshheading:9805250-Predictive Value of Tests,
pubmed-meshheading:9805250-Prednisolone,
pubmed-meshheading:9805250-Retrospective Studies,
pubmed-meshheading:9805250-Treatment Outcome
|
pubmed:year |
1998
|
pubmed:articleTitle |
A new scoring system to predict the efficacy of steroid therapy for patients with active myocarditis--a retrospective study.
|
pubmed:affiliation |
First Department of Internal Medicine, Niigata University School of Medicine, Japan.
|
pubmed:publicationType |
Journal Article
|